Syndax Pharmaceuticals, Inc. (SNDX)
19.57
-0.08
(-0.41%)
USD |
NASDAQ |
Aug 24, 16:00
19.70
+0.13
(+0.66%)
After-Hours: 20:00
Syndax Pharmaceuticals Market Cap : 1.745B for Aug. 24, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.745B |
| August 21, 2026 | 1.752B |
| August 20, 2026 | 1.761B |
| August 19, 2026 | 1.852B |
| August 18, 2026 | 1.775B |
| August 17, 2026 | 1.762B |
| August 14, 2026 | 1.769B |
| August 13, 2026 | 1.701B |
| August 12, 2026 | 1.765B |
| August 11, 2026 | 1.809B |
| August 10, 2026 | 1.816B |
| August 07, 2026 | 1.819B |
| August 06, 2026 | 1.762B |
| August 05, 2026 | 1.776B |
| August 04, 2026 | 1.701B |
| August 03, 2026 | 1.715B |
| July 31, 2026 | 1.687B |
| July 30, 2026 | 1.725B |
| July 29, 2026 | 1.702B |
| July 28, 2026 | 1.738B |
| July 27, 2026 | 1.817B |
| July 24, 2026 | 1.843B |
| July 23, 2026 | 1.878B |
| July 22, 2026 | 1.952B |
| July 21, 2026 | 2.005B |
| Date | Value |
|---|---|
| July 20, 2026 | 1.974B |
| July 17, 2026 | 2.019B |
| July 16, 2026 | 2.011B |
| July 15, 2026 | 2.083B |
| July 14, 2026 | 2.137B |
| July 13, 2026 | 2.027B |
| July 10, 2026 | 2.091B |
| July 09, 2026 | 2.199B |
| July 08, 2026 | 2.175B |
| July 07, 2026 | 2.058B |
| July 06, 2026 | 1.955B |
| July 02, 2026 | 1.932B |
| July 01, 2026 | 1.850B |
| June 30, 2026 | 1.936B |
| June 29, 2026 | 1.928B |
| June 26, 2026 | 1.887B |
| June 25, 2026 | 1.754B |
| June 24, 2026 | 1.769B |
| June 23, 2026 | 1.736B |
| June 22, 2026 | 1.711B |
| June 18, 2026 | 1.682B |
| June 17, 2026 | 1.686B |
| June 16, 2026 | 1.642B |
| June 15, 2026 | 1.636B |
| June 12, 2026 | 1.616B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Viking Therapeutics, Inc. | 3.876B |
| Kura Oncology, Inc. | 1.103B |
| ACADIA Pharmaceuticals, Inc. | 5.104B |
| Alnylam Pharmaceuticals, Inc. | 31.56B |
| Anika Therapeutics, Inc. | 285.59M |
Market Cap Related Metrics
| PS Ratio | 6.812 |
| Price to Book Value | 115.55 |
| Price | 19.57 |
| Earnings Yield | -12.87% |